Key result
Radiofrequency ablation and transcatheter cryoablation achieved a 100% acute success rate in neonates and infants with drug-resistant supraventricular tachycardia.
Why the study?
Does catheter ablation (RFA or TCA) improve symptoms and eliminate the need for medication in neonates and infants with drug-resistant SVT?
Population
5 neonates and infants with recurrent hemodynamically compromising drug-resistant supraventricular…
Design
Case_series
Follow-up
average 6.5 months (range 3-18)
Authors
Loading...
Hypothesis-generating for ablation in refractory neonatal SVT; prospective trials needed before practice change.
Observational (n=5)
No
Does catheter ablation (RFA or TCA) improve symptoms and eliminate the need for medication in neonates and infants with drug-resistant SVT?
Catheter ablation (RFA and TCA) can be safely and successfully performed in neonates and infants with medically refractory, hemodynamically compromising SVT.
Akdeniz et al. (2013) conducted an observational in Drug-resistant supraventricular tachycardia (SVT) (n=5). Radiofrequency ablation (RFA) and transcatheter cryoablation (TCA) was evaluated on Acute success rate. Radiofrequency ablation and transcatheter cryoablation achieved a 100% acute success rate in neonates and infants with drug-resistant supraventricular tachycardia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: